March 9, 2010 (San Antonio, Texas) — The phosphodiesterase inhibitor cilostazol is more effective in secondary stroke prevention and has a significantly lower incidence of serious cerebral hemorrhage ...
The European Medicines Agency has recommended restricting the use of cilostazol-containing medicines in the treatment of intermittent claudication to a narrower patient population in which there are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results